1. Home
  2. TRS vs PRGO Comparison

TRS vs PRGO Comparison

Compare TRS & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriMas Corporation

TRS

TriMas Corporation

HOLD

Current Price

$41.37

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Perrigo Company plc

PRGO

Perrigo Company plc

HOLD

Current Price

$11.00

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRS
PRGO
Founded
1986
1887
Country
United States
Ireland
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.6B
IPO Year
2004
2013

Fundamental Metrics

Financial Performance
Metric
TRS
PRGO
Price
$41.37
$11.00
Analyst Decision
Strong Buy
Buy
Analyst Count
2
3
Target Price
$41.50
$19.33
AVG Volume (30 Days)
350.1K
2.9M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
0.44%
10.28%
EPS Growth
400.00
N/A
EPS
21.40
N/A
Revenue
$645,720,000.00
$800,000.00
Revenue This Year
$5.42
N/A
Revenue Next Year
$4.27
$1.02
P/E Ratio
$1.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.57
$9.23
52 Week High
$43.72
$28.44

Technical Indicators

Market Signals
Indicator
TRS
PRGO
Relative Strength Index (RSI) 59.56 48.70
Support Level $35.40 $10.37
Resistance Level $41.84 $11.85
Average True Range (ATR) 1.15 0.56
MACD 0.04 0.03
Stochastic Oscillator 89.97 44.32

Price Performance

Historical Comparison
TRS
PRGO

About TRS TriMas Corporation

TriMas Corp designs, develops and manufactures a diverse set of products for the consumer products, and industrial markets . The company operates through two segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners. The packaging segment generates majority of its revenue.

About PRGO Perrigo Company plc

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Share on Social Networks: